Susan Babirye
ID: UNCST-2021-R013201
|
Analysis of the impact of COVID-19 on employment, economic status, and HIV risk and vulnerability among women living in urban informal settlements in two cities in Uganda: a participatory action research
REFNo: HS2458ES
1. To evaluate the impact of COVID-19 on employment (paid and unpaid work) and socio-economic status of women living in urban informal settlements in Kampala and Mbale city.
2. To determine how the changes in employment and economic status have influenced risk and vulnerability to HIV among women living in urban informal settlements in Kampala and Mbale city.
3. To explore the strategies implemented by women living in urban informal settlements in Kampala and Mbale city to cope with COVID-19-related work stress that expose them to HIV risk and vulnerability.
4. To examine the difference between existing COVID-19 recovery interventions in Uganda and the current socioeconomic and health needs of women living in urban informal settlements in Kampala and Mbale city as regards to safeguarding from HIV risk and vulnerability.
5. To convene key stakeholders to deliberate on the findings of study questions 1, 2, 3 and 4 in order to collectively identify and co-design gender transformative solutions to improve the socioeconomic well-being and reduce HIV risk and vulnerability among women living in urban informal settlements and living with HIV.
|
Uganda |
2022-09-23 12:39:21 |
2025-09-23 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Eddy Walakira Joshua
ID: UNCST-2022-R009077
|
Costs and benefits of ethical recruitment to Overseas Private Recruitment Agencies
in Uganda
REFNo: SS1410ES
The objective of this case study is to use a market-based lens to assess the business case for the IRIS CBP in the Ugandan context.
|
Uganda |
2022-09-23 12:32:59 |
2025-09-23 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Joseph OPUL
ID:
|
Contribution of Education to Resilience of Refugee Learners, A Case Study of Primary Schools in Nakivale Settlement, Isingiro District, Western Uganda
REFNo: SS1448ES
i.To assess the contribution of the curriculum to resilience of refugee learners; A case study of primary schools in Nakivale refugee’s settlement, Isingiro District, Western Uganda.
ii.To examine the role of teachers in resilience of refugee learners; A case study of primary schools in Nakivale refugee’s settlement, Isingiro District, Western Uganda.
iii.To examine the role of school leadership in resilience of refugee learners; A Case study of Primary schools in Nakivale refugee’s settlement, Isingiro District, Western Uganda.
|
Uganda |
2022-09-23 12:15:46 |
2025-09-23 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Rose Nakasi
ID: UNCST-2022-R010805
|
Building AI Based Models for Diagnosis of Malaria
REFNo: SIR131ES
General Objective
To develop machine learning diagnostic systems from thick and thin blood smear image datasets for automated diagnosis of malaria in Uganda.
Specific Objectives
To achieve this, the project will have the following specific objectives;
1. To collect, curate and generate an open and labeled standardized malaria image dataset of thick and thin blood smear images from Uganda.
2. Develop machine learning models for automated detection of malaria in thick and thin blood smear images.
3. To build mobile and web-based applications for automated diagnosis of malaria.
4. To validate the developed ML models with expert ground truth annotations for malaria diagnosis.
|
Uganda |
2022-09-23 12:14:44 |
2025-09-23 |
Engineering and Technology |
Non-Clinical Trial |
Non-degree Award |
|
Shamilah Namusisi
ID:
|
Improving Household and Community Practices to reduce human contact with bats in Bundibugyo District
REFNo: SS1406ES
To determine the effectiveness of the “Living Safely with Bats” model developed by the USAID-PREDICT project at a community level. ,Improve community knowledge of, and increase uptake of safety practices through a multi-pronged social and behavior change (SBC) strategy.,Engage local women, women groups and school clubs in testing out plants that repel bats due to their scent, including as mint and rosemary.,Identify locally available and affordable materials to keep bats out of homes and community buildings. ,The overall goal of this intervention is to reduce the risk of exposure from pathogens arising as a result of human contact with bats by deterring bats from entering houses and buildings, as well as improving household and community safety practices once the bats have already entered or roosted.,
|
Uganda |
2022-09-23 11:53:17 |
2025-09-23 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
BRENDA KHARONO
ID:
|
Stage of Maternal and Perinatal Death Surveillance and Response (MPDSR) implemented in Regional Referral Hospitals in Uganda-A mixed Methods Study
REFNo: HS2425ES
2. Enablers and Factors to MPDSR Implementation across the above RRHs,1. To describe the level of implementation of MPDSR in regional referral hospitals in Uganda,The purpose of this study is to describe the level of implementation of MPDSR in regional referral hospitals in Uganda. ,
|
Uganda |
2022-09-21 21:36:30 |
2025-09-21 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Nikita Bedov
ID:
|
Evolution and Behavioural Ecology of Natural Predator Interactions Between Mongooses and Snakes
REFNo: NS398ES
The overall objective is to analyse interactions between mongooses and snakes using model presentations. I want to understand how anti-snake behaviour varies across mongoose species and between groups with different compositions (by age, dominance, experience and sociality). Furthermore, I will examine ecological effects on mongoose-snake interactions by a comparison across geographic areas in Africa with different ecosystems and different guilds and combinations of snake and mongoose species.
By carrying out model presentations to the banded mongooses in Uganda, I aim to achieve the following:
1. To characterise banded mongoose foraging and hunting behaviour on snakes by observing how individuals interact with models of different snake species and models of other prey items, recording their physical behaviour and vocalisations.
2. To investigate whether different stimuli of the snake models, specifically movement of the model or the addition of natural snake scent, cause differences in behaviour mongooses exhibit towards them.
3. To investigate whether response to snakes varies under different group and environmental factors, such as in different group sizes and compositions, at varying distance from den or cover, or when pups are present.
4. To examine if mongooses have individual-level patterns or ‘defensive personalities’ by relating behavioural observations with life-history data from the long-term records about the same mongoose individuals collected by the Banded Mongoose Project.
|
Spain |
2022-09-21 21:34:08 |
2025-09-21 |
Natural Sciences |
Non-Clinical Trial |
Degree Award |
|
Byamah Mutamba Brian
ID: UNCST-2022-R011124
|
Strengthening Care in collaborAtion with People with lived Experience of psychosis in Uganda (SCAPE-U
REFNo: HS2327ES
General objective
To assess the impact of SCAPE-U on individual, family members’ and health system outcomes, and evaluate trial procedures to determine the optimal design for a future fully-powered cluster randomised controlled trial (RCT).
Specific objectives
1. To assess the feasibility and acceptability of SCAPE-U from the perspective of people with lived experience of psychosis, their family members and primary and community care providers.
2. To demonstrate proof-of-concept for the benefit of SCAPE-U for service users (i.e., patients with psychosis receiving primary care services) and their families, including changes in psychosis symptoms, quality of life, frequency of hospitalization and the potential impacts on family members.
3. To determine changes in health systems outcomes in terms of primary care provider knowledge, attitudes, competency in psychosis diagnosis and management, as well as accuracy of diagnosis and fidelity to treatment guidelines in actual care settings.
4. To evaluate trial procedures, including costing, recruitment and retention, and data collection protocols, to determine the optimal design for a future fully-powered cluster RCT
|
Uganda |
2022-09-21 21:32:50 |
2025-09-21 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Jagoda Byszko Magdalena
ID:
|
"Understanding origins of social brain and communication in wild primates"
REFNo: NS335ES
Determining the complexity and diversity of chimpanzee gestural and voice communication repertoire. Identifying communication differences depending on social and environmental factors. Identifying patterns of social structures and the factors that influence them. Determining whether and to what extent gestural communication contributes to the creation and maintenance of complex social systems.
|
Poland |
2022-09-21 21:27:15 |
2025-09-21 |
Natural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Henry Ssenyondo
ID:
|
Maternal Antibody in Milk After Group B Streptococcus Vaccination in Uganda: MAMA study
REFNo: HS1986ES
General Objective
• To determine the concentration of antibody transferred in breastmilk following vaccination with Group B Streptococcal vaccine
Specific Objectives
• To determine the anti-GBS (anti-Alp1N, Alp2N, AlpCN and RibN) Immunoglobulin A (IgA) concentrations in the colostrum of women following vaccination with a GBS-containing vaccine or placebo in pregnancy.
• To determine the total IgA and Immunoglobulin G (IgG) concentrations in the colostrum and breastmilk of women at less than 48 hours, 28 (+/-4 days) and 56 (+/- 6 days) days after delivery following vaccination with a GBS-containing vaccine or placebo in pregnancy.
• To determine the anti-GBS (antiAlp1N, Alp2N, AlpCN and RibN) IgA concentrations in the breastmilk of women at 28 (+/-4 days) and 56 (+/- 6 days) days after delivery following vaccination with a GBS-containing vaccine in pregnancy.
• To determine the anti-GBS (antiAlp1N, Alp2N, AlpCN and RibN) IgG concentrations in the colostrum and breastmilk of women at less than 48 hours, 28 (+/-4 days) and 56 (+/- 6 days) days after delivery following vaccination with a GBS-containing vaccine in pregnancy.
|
Uganda |
2022-09-21 21:13:49 |
2025-09-21 |
Medical and Health Sciences |
Clinical Trial |
Degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|